Post by Bayer
7,015,846 followers
+++ #NEWS +++ We’re excited to announce that our next generation low-dose MRI contrast agent has received regulatory approval in the U.S. The demand for innovation in medical imaging is fueled by an aging population and an increase in chronic diseases such as cancer. As a long‑standing leader in radiology, #TeamBayer is proud to play a key role in the evolution of medical imaging and to continue delivering patient-focused care. You can find more about this recent milestone here: https://lnkd.in/ekY-krjA
Video Content